Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acro Biomedical CoROCO:6748 -5.10%66 Days Inventory is 217.72 as of Dec. 2025, which is 52% below its 10-year median of 449.49. GuruFocus rates ROCO:6748 with a GF Score™ of 66/100 and a GF Value™ of NT$32.13 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 638 Biotechnology companies, Acro Biomedical Co ranks worse than 57.37% on this metric.
The historical rank and industry rank for Acro Biomedical Co's Days Inventory or its related term are showing as below:
ROCO:6748'
s Days Inventory Range Over the Past 10 Years
Min: 204.46 Med: 449.49 Max: 1778.45
Current: 215.23
During the past 8 years, Acro Biomedical Co's highest Days Inventory was 1778.45. The lowest was 204.46. And the median was 449.49.
ROCO:6748's Days Inventory is ranked worse than 57.37% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs ROCO:6748: 215.23
Acro Biomedical Co's Days Inventory
increased
from Dec. 2024 (194.74) to Dec. 2025 (217.72).
It might indicate that Acro Biomedical Co's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Acro Biomedical Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.84.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Acro Biomedical Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.49.
Acro Biomedical Co (ROCO:6748) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Acro Biomedical Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Acro Biomedical Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Acro Biomedical Co Days Inventory Related Terms
Acro Biomedical Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Acro Biomedical Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6748 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Acro Biomedical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acro Biomedical Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Acro Biomedical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Acro Biomedical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acro Biomedical Co (ROCO:6748) has a Days Inventory of 217.72 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Acro Biomedical Co and its competitors. This is 52% below median its historical median of 449.49. Over the past decade, Acro Biomedical Co's Days Inventory has ranged from 204.46 to 1,778.45. According to the industry distribution chart, Acro Biomedical Co ranks #366 out of 638 companies in the Biotechnology industry, placing it in the top 57.4%.
Is Acro Biomedical Co's Days Inventory too high?
Acro Biomedical Co's current Days Inventory of 217.72 is 52% below median its 10-year median of 449.49. Over the past 10 years, this metric has ranged from a low of 204.46 to a high of 1,778.45. The Biotechnology industry median Days Inventory is 183.20. Acro Biomedical Co's value of 217.72 is 18.8% above this industry median. Based on the distribution chart, Acro Biomedical Co ranks #366 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Acro Biomedical Co has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Acro Biomedical Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Acro Biomedical Co ranks #366 out of 638 companies for Days Inventory. This places Acro Biomedical Co in the lower half of its industry. The industry median Days Inventory is 183.20. Acro Biomedical Co's value of 217.72 is 18.8% above this benchmark. Historically, Acro Biomedical Co's own Days Inventory has ranged from 204.46 to 1,778.45 over the past decade. While the company's 10-year median is 449.49 vs. the industry median of 183.20, Acro Biomedical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acro Biomedical Co's current Days Inventory of 217.72 is 18.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Acro Biomedical Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acro Biomedical Co's current Days Inventory is 217.72, which is 52% below median its own 10-year median of 449.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acro Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Acro Biomedical Co (ROCO:6748) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$32.13, compared to a current price of NT$260.50 — trading 710.8% above its estimated fair value. The current Days Inventory is 217.72, which is 52% below median its 10-year median of 449.49 and 18.8% above the Biotechnology industry median of 183.20. Acro Biomedical Co's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Acro Biomedical Co (ROCO:6748), the current Days Inventory is 217.72 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acro Biomedical Co (ROCO:6748) Overvalued in 2026?
Based on GuruFocus' analysis, Acro Biomedical Co stock appears to be overvalued.
The current stock price of NT$260.50 is trading 710.8% above its estimated GF Value™ of NT$32.13.
GuruFocus considers Acro Biomedical Co to be Significantly Overvalued.
Key valuation signals for ROCO:6748:
Days Inventory: 217.72 (52% below median its 10-year median of 449.49)
GF Value™: NT$32.13 vs. price of NT$260.50 (710.8% above fair value)
Industry Position: 18.8% above the Biotechnology median (#366 of 638)
No single metric tells the full story. See the ROCO:6748 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acro Biomedical Co Ltd is a company whose technical team integrates the Research and development capabilities of Taiwan's major scientific research units and medical centers to jointly develop equipment for repairing organs and tissues in various parts of the human body. It mainly focuses on orthopedics, dentistry, cardiovascular specialists, ophthalmology, surgery, wound care, Medical equipment used in sports injuries and other specialties.
66GF Score
Get the complete analysis for ROCO:6748
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6748 has been successfully added to your 
